1. HbA1c in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
- Author
-
Bernal-Lopez, M. R., Santamaría-Fernandez, S., Lopez-Carmona, D., Tinahones, F. J., Mancera-Romero, J., Peña-Jimenez, D., Jansen-Chaparro, S., Baca-Osorio, A. J., Cuesta-Muñoz, A. L., Serrano-Rios, M., and Gomez-Huelgas, R.
- Subjects
BLOOD sugar analysis ,DIAGNOSIS of diabetes ,ANALYSIS of variance ,CHI-squared test ,EPIDEMIOLOGY ,FASTING ,GLYCOSYLATED hemoglobin ,MEDICAL protocols ,MEDICAL practice ,SMOKING ,DATA analysis ,BODY mass index ,CROSS-sectional method ,WAIST-hip ratio ,DATA analysis software - Abstract
Diabet. Med. 28, 1319-1322 (2011) Abstract Aims To analyse the differences in the prevalence of diabetes and dysglycaemia using fasting plasma glucose and HbA
1c criteria. Methods Analytical cross-sectional study undertaken in a random sample of 2144 individuals (age 18-80 years) without known diabetes from the primary care setting in Malaga (Spain). Dysglycaemia was defined as fasting plasma glucose 5.6-6.9 mmol/l or HbA1c 39-46 mmol/mol (5.7-6.4%) and diabetes as fasting plasma glucose ≥ 7.0 mmol/l or HbA1c ≥ 48 mmol/mol (≥ 6.5%). Results The proportion of subjects who were normoglycaemic was significantly higher using fasting plasma glucose than HbA1c (83.5 vs. 65%) ( P < 0.0001). Compared with fasting plasma glucose, HbA1c detects more cases of dysglycaemia (32 vs. 14.8%) ( P < 0.0001) and diabetes (3 vs. 1.7%) ( P < 0.0001). Conclusions In our environment, using HbA1c for the diagnosis of pre-diabetes and diabetes could increase the target population for preventive and therapeutic measures. Further cost-effectiveness studies are needed before the widespread diagnostic use of HbA1c can be recommended. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF